Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-037-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Remarks:
- Early study, but reporting the main relevant details, No GLP, short report
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Remarks:
- pre-dates GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Reaction mass of sodium sulphate and trisodium trioxalatoferrate
- EC Number:
- 947-037-7
- IUPAC Name:
- Reaction mass of sodium sulphate and trisodium trioxalatoferrate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CFY strain
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 100 -116 g
- Fasting period before study: overnight
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 %
MAXIMUM DOSE VOLUME APPLIED: 5,3 to 21,3 ml - Doses:
- 0 - 1,0 - 1,6 - 2,5 - 4 - 6,4 g /kg
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Results and discussion
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 300 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 2 000 - < 2 700
- Mortality:
- Death occurred between 1 and 22 hours after treatment. The lowest fatal dose was 1000 mg/kg bw.
- Clinical signs:
- other: Signs of reaction to treatment, observed shortly after dosing, included lethargy, pilo-erection, slight diuresis and slight decrease in respiratory rate. Loss of righting was seen in rats treated at 5 and 6.4g/kg. Rats treated at 6.4 g/kg also showed an i
- Gross pathology:
- Autopsy revealed haemorrohage of the stomach and darkening of the liver in deceased anmals only.
Any other information on results incl. tables
Dose (mg/kg) |
Mean Body weight (g) |
Mortality (x / n) |
Time of death (h) |
||
Dosing |
1 week |
2 weeks |
|||
0 |
104 |
177 |
238 |
0/10 |
- |
1000 |
115 |
152 |
238 |
1/10 |
<20 |
1600 |
105 |
165 |
226 |
0/10 |
- |
2500 |
104 |
168 |
232 |
7/10 |
<20 |
4000 |
101 |
died |
- |
10/10 |
<19 |
6400 |
104 |
died |
- |
10/10 |
<20 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute median lethal oral dose (LD 50) and its 95% confidence limits to rats of the test item were calculated to be:
2300 (2000 to 2700) mg/kg bodyweight. - Executive summary:
Male rats of the CFY strain in the weight range 100 to 116 g were starved overnight before treatment with the test item. The test material was prepared as a 30% aqueous solution and administered by oral intubation at varying dosage volumes in the test of 5.3 to 21.3 ml/kg bodyweight. Rats dosed with water alone (21.3 ml/kg) served as controls.
During the observation period of 14 days a record was kept of all mortalities and signs of toxicity. All rats that died were examined macroscopically in arn attempt to identify the target organs, and those animals surviving terminally were similarly examined to detect possible residual damage.
From the mortality data recorded the LD 50 and its 95% confidence limits were calculated by the method of Weil C.S. (1952), Biometrics 8, 249.
RESULTS
Signs of reaction to treatment, observed shortly after dosing, included lethargy, pilo-erection, slight diuresis and slight decrease in respiratory rate. Loss of righting was seen in rats lreated at 5 and 6.4 g/kg. Rats treated at 6.4 g/kg also showed an increase in salivation.
Death occurred between 1 and 22 hours after treatment. Autopsy revealed haemorrohage of the stomach and darkening of the liver.
Recovery of survivors as judged by external appearance and behaviour, was apparently complete within 3 days of treatment. Bodyweight increases were depressed during the first week of the observation period but were normal during the second week compared with controls. Autopsy findings were normal.
CONCLUSION
The acute median lethal oral dose (LD 50) and its 95% confidence limits to rats of the test item were calculated to be:
2300 (2000 to 2700) mg/kg bodyweight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.